|1.||Sugahara, Kazuyuki: 14 articles (10/2015 - 01/2004)|
|2.||Salanti, Ali: 13 articles (02/2014 - 07/2003)|
|3.||van Kuppevelt, Toin H: 11 articles (11/2014 - 06/2003)|
|4.||Vergés, Josep: 10 articles (01/2015 - 01/2004)|
|5.||Volpi, Nicola: 9 articles (06/2014 - 06/2004)|
|6.||Yamada, Shuhei: 8 articles (10/2015 - 01/2004)|
|7.||Fried, Michal: 8 articles (04/2013 - 07/2002)|
|8.||Nielsen, Morten A: 8 articles (02/2013 - 01/2008)|
|9.||Theander, Thor G: 8 articles (02/2013 - 07/2003)|
|10.||Scherf, Artur: 8 articles (02/2013 - 08/2002)|
03/01/2013 - "This review summarizes data from relevant reports describing the mechanisms of action of chondroitin sulfate that may explain the beneficial effects of the drug and examines the evidence for clinical efficacy of oral chondroitin sulfate in osteoarthritis. "
03/01/2008 - "Exogenous administration of chondroitin sulfate (CS) is widely practiced for the treatment of osteoarthritis, although the efficacy of this treatment has not been completely established by clinical studies. "
03/01/2013 - "Chondroitin sulfate is an effective and safe treatment option for patients with osteoarthritis."
01/01/2012 - "To perform a meta-analysis of randomized double-blind placebo-controlled clinical trials to assess the efficacy of a specific chondroitin sulfate preparation (Structum®, Laboratoires Pierre Fabre, Castres; France) as a symptom-modifying drug in osteoarthritis (OA) of the knee. "
01/01/2000 - "To examine the efficacy of chondroitin sulfate (CS) in the treatment of osteoarthritis (OA) on the basis of a metaanalysis of controlled clinical trials. "
01/01/2014 - "The study shows sufficient decreasing of pain, stiffness and functional disorders with complex therapy with chondroitin sulfate in comparison with nonsteroidal anti-inflammatory drugs (NSAID) by the second month of therapy with stable effect the next 2 months. "
03/01/2013 - "Clinical trials have reported a beneficial effect of chondroitin sulfate on pain and function. "
05/01/1999 - "All four studies showed chondroitin sulfate to be superior to placebo, with respect to Lequesne index, visual analog scale for pain and medication consumption. "
05/01/1998 - "This limited study confirmed that chondroitin sulfate was well-tolerated and both significantly reduced pain and increased overall mobility capacity. "
06/01/2012 - "Intravesical chondroitin sulfate therapy for IC/BPS might result in minor improvements in IC/BPS-related symptom and pain. "
03/01/2005 - "To determine whether chondroitin sulfate (CS) is effective in inhibiting cartilage loss in knee osteoarthritis (OA). "
06/01/2010 - "To update a published meta-analysis of double-blind placebo-controlled randomized clinical trials (RCTs) to assess the efficacy of chondroitin sulfate as a structure-modifying drug for knee osteoarthritis (OA). "
01/01/2012 - "Symptom-modifying effect of chondroitin sulfate in knee osteoarthritis: a meta-analysis of randomized placebo-controlled trials performed with structum(®)."
06/01/2010 - "Structure-modifying effects of chondroitin sulfate in knee osteoarthritis: an updated meta-analysis of randomized placebo-controlled trials of 2-year duration."
05/01/1998 - "This multicenter randomized, double-blind, controlled study was performed to compare the efficacy and tolerability of chondroitin sulfate (CS, Condrosulf, IBSA, Lugano, CH) 1200 mg/day oral gel vs CS 3 x 400 mg/day capsules vs placebo, in patients with mono or bilateral knee osteoarthritis (Kellgren and Lawrence radiographic score grade I to III). "
10/01/2006 - "Immunogenicity of Duffy binding-like domains that bind chondroitin sulfate A and protection against pregnancy-associated malaria."
01/01/2015 - "Expression of the VAR2CSA variant of PfEMP1 leads to pregnancy-associated malaria, which occurs when infected erythrocytes massively sequester in the placenta by binding to low-sulfated Chondroitin Sulfate A (CSA) present in the intervillous spaces. "
07/01/2014 - "In placental malaria (PM), sequestration of infected erythrocytes in the placenta is mediated by an interaction between VAR2CSA, a Plasmodium falciparum protein expressed on erythrocytes, and chondroitin sulfate A (CSA) on syncytiotrophoblasts. "
01/01/2014 - "The placental sequestration of Plasmodium falciparum infected erythrocytes (IE) is the major feature of malaria during pregnancy, due to ability of these parasites to bind chondroitin sulfate A (CSA) in the placenta through the VAR2CSA protein that parasites express on the surface of IE. "
06/01/2013 - "In malaria, STB denudation exposed CD36 and chondroitin sulfate A in the villous cores to maternal blood, and STB expressed ICAM1. "
|5.||Urinary Tract Infections (Urinary Tract Infection)
10/01/2013 - "The aim of our study was to assess whether intravesical therapy with hyaluronic acid (HA) and chondroitin sulfate (CS) is more effective than antibiotic therapy in reducing episodes and symptoms of recurrent urinary tract infections. "
12/01/2012 - "Editorial comment to intravesical hyaluronic acid and chondroitin sulfate alone and in combination for urinary tract infection: assessment of protective effects in a rat model."
12/01/2012 - "To determine the protective effects of hyaluronic acid and chondroitin sulfate in treating urinary tract infections in a rat model. "
12/01/2012 - "Intravesical hyaluronic acid and chondroitin sulfate alone and in combination for urinary tract infection: assessment of protective effects in a rat model."
|2.||Hyaluronic Acid (Hyaluronan)
|3.||Chondroitin Sulfates (Chondroitin Sulfate)
|6.||Heparitin Sulfate (Heparan Sulfate)
|8.||Collagen Type II (Type II Collagen)
|3.||Guided Tissue Regeneration